Cargando…

AI-powered drug repurposing for developing COVID-19 treatments

Emerging infectious diseases are an ever-present threat to public health, and COVID-19 is the most recent example. There is an urgent need to develop a robust framework to combat the disease with safe and effective therapeutic options. Compared to de novo drug discovery, drug repurposing may offer a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhichao, Chen, Xi, Carter, Wendy, Moruf, Alicia, Komatsu, Takashi E., Pahwa, Sonia, Chan-Tack, Kirk, Snyder, Kevin, Petrick, Nicholas, Cha, Kenny, Lal-Nag, Madhu, Hatim, Qais, Thakkar, Shraddha, Lin, Yu, Huang, Ruili, Wang, Dong, Patterson, Tucker A., Tong, Weida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865759/ http://dx.doi.org/10.1016/B978-0-12-824010-6.00005-8

Ejemplares similares

AI-based language models powering drug discovery and development
por: Liu, Zhichao, et al.
Publicado: (2021)

Editorial: Emerging Technologies Powering Rare and Neglected Disease Diagnosis and Theraphy Development
por: Liu, Zhichao, et al.
Publicado: (2022)

Adaptability of AI for safety evaluation in regulatory science: A case study of drug-induced liver injury
por: Connor, Skylar, et al.
Publicado: (2022)

DICE: A Drug Indication Classification and Encyclopedia for AI-Based Indication Extraction
por: Bhatt, Arjun, et al.
Publicado: (2021)

Scaling bioinformatics applications on HPC
por: Mikailov, Mike, et al.
Publicado: (2017)

Deep Learning on High-Throughput Transcriptomics to Predict Drug-Induced Liver Injury
por: Li, Ting, et al.
Publicado: (2020)

DeepCarc: Deep Learning-Powered Carcinogenicity Prediction Using Model-Level Representation
por: Li, Ting, et al.
Publicado: (2021)

Corrigendum: DeepCarc: Deep learning-powered carcinogenicity prediction using model-level representation
por: Li, Ting, et al.
Publicado: (2022)

Informing selection of drugs for COVID-19 treatment through adverse events analysis
por: Guo, Wenjing, et al.
Publicado: (2021)

Deciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for cystic fibrosis
por: Liu, Zhichao, et al.
Publicado: (2014)

The FDA’s Experience with Emerging Genomics Technologies—Past, Present, and Future
por: Xu, Joshua, et al.
Publicado: (2016)

Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs
por: Hong, Huixiao, et al.
Publicado: (2017)

Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations
por: Li, Dan, et al.
Publicado: (2020)

AI/ML-driven advances in untargeted metabolomics and exposomics for biomedical applications
por: Petrick, Lauren M., et al.
Publicado: (2022)

Repurposing Zileuton as a Depression Drug Using an AI and In Vitro Approach
por: Kubick, Norwin, et al.
Publicado: (2020)

Application of dynamic topic models to toxicogenomics data
por: Lee, Mikyung, et al.
Publicado: (2016)

DeepCausality: A general AI-powered causal inference framework for free text: A case study of LiverTox
por: Wang, Xingqiao, et al.
Publicado: (2022)

Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods
por: Choudhury, Chinmayee, et al.
Publicado: (2022)

Comprehensive Assessments of RNA-seq by the SEQC Consortium: FDA-Led Efforts Advance Precision Medicine
por: Xu, Joshua, et al.
Publicado: (2016)

AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate()
por: Delijewski, Marcin, et al.
Publicado: (2021)

Unraveling Gene Fusions for Drug Repositioning in High-Risk Neuroblastoma
por: Liu, Zhichao, et al.
Publicado: (2021)

Repurposing drugs as COVID-19 therapies: A toxicity evaluation
por: Ngan, Deborah K., et al.
Publicado: (2022)

The claudins
por: Lal-Nag, Madhu, et al.
Publicado: (2009)

AI-driven drug repurposing and binding pose meta dynamics identifies novel targets for monkeypox virus
por: Patel, Chirag N., et al.
Publicado: (2023)

Profiling the BLAST bioinformatics application for load balancing on high-performance computing clusters
por: Cheng, Trinity, et al.
Publicado: (2022)

Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
por: Wu, Leihong, et al.
Publicado: (2019)

Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation
por: Dalwadi, Shraddha M., et al.
Publicado: (2023)

On the Social-Relational Moral Standing of AI: An Empirical Study Using AI-Generated Art
por: Lima , Gabriel, et al.
Publicado: (2021)

Drug repurposing approach to fight COVID-19
por: Singh, Thakur Uttam, et al.
Publicado: (2020)

Exploring NCATS In-House Biomedical Data for Evidence-based Drug Repurposing
por: Liu, Fang, et al.
Publicado: (2023)

Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform
por: Chakravarty, Kaushik, et al.
Publicado: (2021)

Identification of repurposed small molecule drugs for chordoma therapy
por: Xia, Menghang, et al.
Publicado: (2013)

Molecular representations in AI-driven drug discovery: a review and practical guide
por: David, Laurianne, et al.
Publicado: (2020)

Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer’s Disease in Real-World Clinical Datasets
por: Wei, Wei-Qi, et al.
Publicado: (2023)

Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity
por: Yip, Ashley Jia Wen, et al.
Publicado: (2022)

AI vs. AI: Can AI Detect AI-Generated Images?
por: Baraheem, Samah S., et al.
Publicado: (2023)

Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach
por: Zhu, Liyuan, et al.
Publicado: (2020)

Classifying Free Texts Into Predefined Sections Using AI in Regulatory Documents: A Case Study with Drug Labeling Documents
por: Gray, Magnus, et al.
Publicado: (2023)

Origin of the ease of association of color names: Comparison between humans and AI
por: Komatsu, Hidehiko, et al.
Publicado: (2022)

Utility of AI models in critical care: union of man and the machine
por: Lal, Amos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g069blneefkp64n5ocup9uc6r8